167 related articles for article (PubMed ID: 15779341)
1. [IFG and IGT in Europe and America: the present and prospective].
Tsujii S; Kuzuya H
Nihon Rinsho; 2005 Feb; 63 Suppl 2():27-33. PubMed ID: 15779341
[No Abstract] [Full Text] [Related]
2. [Borderline type, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG): their concepts, classification and significance].
Kuzuya T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():15-20. PubMed ID: 15779339
[No Abstract] [Full Text] [Related]
3. [Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy].
Igarashi M; Tominaga M
Nihon Rinsho; 2005 Feb; 63 Suppl 2():55-60. PubMed ID: 15779345
[No Abstract] [Full Text] [Related]
4. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
Petersen JL; McGuire DK
Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
[TBL] [Abstract][Full Text] [Related]
5. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD.
Xu L; Jiang CQ; Lam TH; Cheng KK; Yue XJ; Lin JM; Zhang WS; Thomas GN
Metabolism; 2010 Mar; 59(3):367-72. PubMed ID: 19828159
[TBL] [Abstract][Full Text] [Related]
6. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
[TBL] [Abstract][Full Text] [Related]
7. [Treatment for patients with impaired glucose tolerance].
Tawaramoto K; Kaku K
Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416
[No Abstract] [Full Text] [Related]
8. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
Sanusi H
Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
[TBL] [Abstract][Full Text] [Related]
9. Glucose and cardiovascular risk.
Fuchs M; Hoekstra JB; Mudde AH
Neth J Med; 2002 Jun; 60(5):192-9. PubMed ID: 12365474
[TBL] [Abstract][Full Text] [Related]
10. [Primary prevention of diabetes--importance of early diagnosis and interventions in IGT & IFG].
Kawamori R
Nihon Rinsho; 2005 Feb; 63 Suppl 2():49-54. PubMed ID: 15779344
[No Abstract] [Full Text] [Related]
11. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
[TBL] [Abstract][Full Text] [Related]
12. Back to the future--do IGT and IFG have value as clinical entities?
Colagiuri S; Borch-Johnsen K; Wareham NJ
Diabetes Res Clin Pract; 2008 Aug; 81(2):131-3. PubMed ID: 18657716
[No Abstract] [Full Text] [Related]
13. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.
Santaguida PL; Balion C; Hunt D; Morrison K; Gerstein H; Raina P; Booker L; Yazdi H
Evid Rep Technol Assess (Summ); 2005 Aug; (128):1-11. PubMed ID: 16194123
[No Abstract] [Full Text] [Related]
14. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.
Gerstein HC; Santaguida P; Raina P; Morrison KM; Balion C; Hunt D; Yazdi H; Booker L
Diabetes Res Clin Pract; 2007 Dec; 78(3):305-12. PubMed ID: 17601626
[TBL] [Abstract][Full Text] [Related]
15. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
[TBL] [Abstract][Full Text] [Related]
16. Impaired glucose tolerance and impaired fasting glucose.
Rao SS; Disraeli P; McGregor T
Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
18. Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study.
Vambergue A; Dognin C; Boulogne A; Réjou MC; Biausque S; Fontaine P
Diabet Med; 2008 Jan; 25(1):58-64. PubMed ID: 18028442
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts.
Qiao Q; Nakagami T; Tuomilehto J; Borch-Johnsen K; Balkau B; Iwamoto Y; Tajima N; ;
Diabetologia; 2000 Dec; 43(12):1470-5. PubMed ID: 11151755
[TBL] [Abstract][Full Text] [Related]
20. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
